Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Uxil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Uxil 110.6mg tablets
0801050ANBCAEAL
|
Uxil | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Uxil 15.8mg tablets
0801050ANBCAAAH
|
Uxil | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Uxil 39.5mg tablets
0801050ANBCABAI
|
Uxil | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Uxil 63.2mg tablets
0801050ANBCACAJ
|
Uxil | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Uxil 79.0mg tablets
0801050ANBCADAK
|
Uxil | Dasatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.